Uncategorised - European Medical Journal

Improving Overall Survival for Patients with Pancreatic Cancer

Chemotherapy treatment before and after pancreatic cancer surgery is the most effective combination for patients. Read more

Prostate Cancer Risk Predictable Through Family History and Genes

A team of researchers have developed CanRisk-Prostate, which will be incorporated into CanRisk, a tool for cancer risk predictions.

Turning patient insights into action

Pharma endeavours to drive positive action from patient insights. Read to find out how they could improve their methodologies and outcomes.

Using Behavioral Science to Help Understand Vaccine Hesitancy

This video details Graves’ research on vaccine hesitancy and the psychological and sociocultural factors behind it. Learn ways to identify and overcome vaccine hesitancy by using valuable, research-based insights and strategies.

Mitigating the rare disease RWD deficit

RWD for rare diseases is scarce, but pharma can work to leverage existing processes and build trust to enhance the scope of available data.

Sales reps, MSLs and the future of CX

In this episode, the team chat to James Harper, Founder and Managing Director, Twentyeightb, about pharma sales, MSLs and more.

Is the generics and biosimilars sector at risk of collapse?

Generics and biosimilars are crucial to healthcare worldwide, but there are challenges in getting these medicine to patients.

Interview: Christopher Chapple

EMJ spoke to Christopher Chapple about his role as Secretary General of the European Association of Urology (EAU)…

Confronting health inequities for transgender patients

The challenges faced by the transgender community are vast, but pharma has the power to drive better health equity. Read more.

EMJ

Infographic: Boehringer Ingelheim | Improve, Protect, Prevent

Infographic: Boehringer Ingelheim | Improve, Protect, Prevent. The publication of this infographic has been funded by Boehringer Ingelheim.